Connors JM - Search Results

1

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia.

Hapgood G, Zheng Y, Sehn LH, Villa D, Klasa R, Gerrie AS, Shenkier T, Scott DW, Gascoyne RD, Slack GW, Parsons C, Morris J, Pickles T, Connors JM, Savage KJ. Hapgood G, et al. Among authors: connors jm. J Clin Oncol. 2016 Jul 20;34(21):2493-500. doi: 10.1200/JCO.2015.65.4194. Epub 2016 Jun 6. J Clin Oncol. 2016. PMID: 27269949

2

Determination of DNA ploidy in archival tissue from non-Hodgkin's lymphoma using flow and image cytometry.

Zbieranowski I, Le Riche JC, Palcic B, Gascoyne R, Connors J. Zbieranowski I, et al. Anal Cell Pathol. 1992 Jul;4(4):303-13. Anal Cell Pathol. 1992. PMID: 1390299

3

Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer.

Osoba D, Band PR, Goldie JH, Connors JM, Gelmon K, Knowling MA, Fetherstonhaugh EM. Osoba D, et al. Among authors: connors jm. Ann Oncol. 1992 Aug;3 Suppl 3:57-62. doi: 10.1093/annonc/3.suppl_3.s57. Ann Oncol. 1992. PMID: 1390318

4

Non-Hodgkin's lymphoma. I: Characterisation and treatment.

O'Reilly SE, Connors JM. O'Reilly SE, et al. Among authors: connors jm. BMJ. 1992 Jun 27;304(6843):1682-6. doi: 10.1136/bmj.304.6843.1682. BMJ. 1992. PMID: 1633525 Free PMC article. Review. No abstract available.

5

Prognostic variables in patients with diffuse large-cell lymphoma treated with MACOP-B.

Hoskins PJ, Ng V, Spinelli JJ, Klimo P, Connors JM. Hoskins PJ, et al. Among authors: connors jm. J Clin Oncol. 1991 Feb;9(2):220-6. doi: 10.1200/JCO.1991.9.2.220. J Clin Oncol. 1991. PMID: 1703227

6

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.

O'Reilly SE, Klimo P, Connors JM. O'Reilly SE, et al. Among authors: connors jm. J Clin Oncol. 1991 May;9(5):741-7. doi: 10.1200/JCO.1991.9.5.741. J Clin Oncol. 1991. PMID: 1707954 Clinical Trial.

7

Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.

Lohri A, Barnett M, Fairey RN, O'Reilly SE, Phillips GL, Reece D, Voss N, Connors JM. Lohri A, et al. Among authors: connors jm. Blood. 1991 May 15;77(10):2292-8. Blood. 1991. PMID: 1709382 Free article.

8

MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.

O'Reilly SE, Hoskins P, Klimo P, Connors JM. O'Reilly SE, et al. Among authors: connors jm. Ann Oncol. 1991 Jan;2 Suppl 1:17-23. doi: 10.1093/annonc/2.suppl_1.17. Ann Oncol. 1991. PMID: 1710485 Free article.

9

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Reece DE, Barnett MJ, Connors JM, Fairey RN, Fay JW, Greer JP, Herzig GP, Herzig RH, Klingemann HG, LeMaistre CF, et al. Reece DE, et al. Among authors: connors jm. J Clin Oncol. 1991 Oct;9(10):1871-9. doi: 10.1200/JCO.1991.9.10.1871. J Clin Oncol. 1991. PMID: 1919637

10

A current analysis of primary lymphoma of the thyroid.

Skarsgard ED, Connors JM, Robins RE. Skarsgard ED, et al. Among authors: connors jm. Arch Surg. 1991 Oct;126(10):1199-203; discussion 1203-4. doi: 10.1001/archsurg.1991.01410340037006. Arch Surg. 1991. PMID: 1929820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

744 results

Search Page